Galectin Therapeutics Reports Third Quarter 2015 Financial Results and Provides Business Update

Go back to Galectin Therapeutics Reports Third Quarter 2015 Financial Results and Provides Business Update
GALECTIN (NASDAQ: GALT) Delayed: 4.16 -0.45 (9.76%)
Previous Close $4.61    52 Week High $3.05 
Open $4.60    52 Week Low $0.49 
Day High $4.65    P/E N/A 
Day Low $4.10    EPS $-1.32 
Volume 283,168